Natural killer cells inhibit hepatitis C virus expression
- PMID: 15339939
- DOI: 10.1189/jlb.0604372
Natural killer cells inhibit hepatitis C virus expression
Abstract
Natural killer (NK) cells are critical in host innate defense against certain viruses. The role of NK cells in controlling hepatitis C virus (HCV) remains obscure. We examined whether NK cells are capable of inhibiting HCV expression in human hepatic cells. When NK cells are cultured with the HCV replicon-containing hepatic cells, they have no direct cytolytic effect but release soluble factor(s) suppressing HCV RNA expression. Media conditioned by NK cell lines (NK-92 and YTS) or primary NK cells isolated from healthy donors contain interferon gamma (IFN-gamma) and potently inhibit HCV RNA expression. Ligation of CD81 on NK cells inhibits IFN-gamma production and results in decreased anti-HCV activity. In addition, the antibodies to IFN-gamma or IFN-gamma receptors abolish the anti-HCV activity of NK cell-conditioned media. The role of IFN-gamma in NK cell-mediated, anti-HCV activity is supported by the observation that NK cell-conditioned media enhanced expression of signal transducer and activator of transcription-1, a nuclear factor that is essential in IFN-gamma-mediated antiviral pathways. NK cell-conditioned media have the ability to stimulate intracellular IFN-alpha expression in the hepatic cells, suggesting a mechanism responsible for NK cell-mediated, anti-HCV activity. Thus, NK cells hold the potential to play a vital role in controlling HCV replication in hepatic cells using an IFN-gamma-dependent mechanism.
Similar articles
-
Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.Hepatology. 2005 Oct;42(4):819-27. doi: 10.1002/hep.20854. Hepatology. 2005. PMID: 16175599
-
Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.Hepatology. 2003 May;37(5):1180-8. doi: 10.1053/jhep.2003.50184. Hepatology. 2003. PMID: 12717400
-
Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells.Antiviral Res. 2007 Feb;73(2):132-9. doi: 10.1016/j.antiviral.2006.08.006. Epub 2006 Sep 12. Antiviral Res. 2007. PMID: 16997390
-
NK cells prevalence, subsets and function in viral hepatitis C.Arch Immunol Ther Exp (Warsz). 2011 Dec;59(6):449-55. doi: 10.1007/s00005-011-0145-y. Epub 2011 Oct 5. Arch Immunol Ther Exp (Warsz). 2011. PMID: 21972016 Review.
-
Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).Clin Ter. 2006 Jul-Aug;157(4):377-86. Clin Ter. 2006. Retraction in: Clin Ter. 2008 May-Jun;159(3):207. PMID: 17051976 Retracted. Review.
Cited by
-
Centrifugal enhancement of hepatitis C virus infection of human hepatocytes.J Virol Methods. 2008 Mar;148(1-2):161-5. doi: 10.1016/j.jviromet.2007.11.002. J Virol Methods. 2008. PMID: 18178263 Free PMC article.
-
Reduction of virus burden-induced splenectomy in patients with liver cirrhosis related to hepatitis C virus infection.World J Gastroenterol. 2006 Apr 7;12(13):2089-94. doi: 10.3748/wjg.v12.i13.2089. World J Gastroenterol. 2006. PMID: 16610063 Free PMC article.
-
Adoptive immunotherapy with liver allograft-derived lymphocytes induces anti-HCV activity after liver transplantation in humans and humanized mice.J Clin Invest. 2009 Nov;119(11):3226-35. doi: 10.1172/JCI38374. Epub 2009 Oct 1. J Clin Invest. 2009. PMID: 19805910 Free PMC article. Clinical Trial.
-
Alterations of the NK cell pool in HIV/HCV co-infection.PLoS One. 2017 Apr 5;12(4):e0174465. doi: 10.1371/journal.pone.0174465. eCollection 2017. PLoS One. 2017. PMID: 28380039 Free PMC article.
-
Activation of natural killer cells by hepatitis C virus particles in vitro.Clin Exp Immunol. 2011 Sep;165(3):352-62. doi: 10.1111/j.1365-2249.2011.04431.x. Epub 2011 Jun 17. Clin Exp Immunol. 2011. PMID: 21682720 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous